Kombinationsmolekyler för genterapi : Konjugat mellan peptider och oligonukleotider
The report examines how the market, as well as purification conditions, forpeptide-oligonucleotide conjugates look like today. These conjugates are intended to be usedin drugs to treat otherwise incurable diseases but so far these types of molecules are still intest-phases and no finished conjugate...
| Main Authors: | , , , , , |
|---|---|
| Format: | Others |
| Language: | Swedish |
| Published: |
Uppsala universitet, Institutionen för biologisk grundutbildning
2021
|
| Subjects: | |
| Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-444231 |